Stockscreener 앱 받기
237.27
2.46%
5.69
시간 외 거래:
233.23
-4.04
-1.70%
전일 마감가:
$231.58
열려 있는:
$231
하루 거래량:
2.32M
Relative Volume:
2.61
시가총액:
$34.83B
수익:
$4.81B
순이익/손실:
$1.11B
주가수익비율:
38.52
EPS:
6.16
순현금흐름:
$1.35B
1주 성능:
-0.52%
1개월 성능:
-1.77%
6개월 성능:
+11.25%
1년 성능:
+36.39%
1일 변동 폭
$231.00
$238.60
1주일 범위
$229.94
$245.19
52주 변동 폭
$164.12
$260.49
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
RMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
Y Intercept Hong Kong Ltd Reduces Position in ResMed Inc. (NYSE:RMD) - MarketBeat
$18.97 Bn Mechanical Ventilator Market Opportunities and - GlobeNewswire
ResMed Inc.'s (NYSE:RMD) institutional investors lost 4.5% last week but have benefitted from longer-term gains - Simply Wall St
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
YieldBoost ResMed From 0.9% To 6.8% Using Options - Nasdaq
ResMed Inc Director Expands Stock Holdings - MSN
XTX Topco Ltd Has $301,000 Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - Yahoo Finance
Franklin Resources Inc. Increases Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
2,216 Shares in ResMed Inc. (NYSE:RMD) Acquired by World Investment Advisors LLC - MarketBeat
ResMed's SWOT analysis: sleep tech giant faces GLP-1 threat, AI opportunity - Investing.com
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
2 ASX companies with the traits of a long-term winner - Morningstar.com.au
Is ResMed Stock Outperforming the Nasdaq? - Nasdaq
Is ResMed Stock Outperforming The Nasdaq? - Barchart
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
Assistive Technology Market Is Booming Worldwide 2024-2031: Dynavox Systems LLC., Invacare Corporation, ResMed - EIN News
Weight-loss drugs draw Americans back to the doctor - Marketscreener.com
The Global Medical Cannula Market Is Poised for Significant Growth USD 447.0 Million by 2034 at a 6.9% of CAGR, driven by Rising Demand for Medical Procedures and Advanced Healthcare Solutions | FMI - GlobeNewswire Inc.
What is William Blair's Estimate for ResMed Q2 Earnings? - MarketBeat
Stifel Initiates Coverage of ResMed Inc.Depositary Receipt () (RSMDF) with Hold Recommendation - MSN
Wellington Management Group LLP Purchases 15,772 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Receives $227.91 Average PT from Brokerages - MarketBeat
Toronto Dominion Bank Has $12.02 Million Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
American Trust Makes New $690,000 Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
Virtu Financial LLC Decreases Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease - Yahoo Finance
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
Why ResMed (RMD) is a Top Value Stock for the Long-Term - Yahoo Finance
ResMed (NYSE:RMD) Now Covered by Analysts at Stifel Nicolaus - MarketBeat
ResMed, The Company Behind Making Sleep Apnea Machines, has Developed The $120 Kontor Head Strap For The Apple Vision Pro To Alleviate Head Strain - Wccftech
Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands - Yahoo Finance
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Geode Capital Management LLC Acquires 380,383 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Purchased by Nomura Asset Management Co. Ltd. - MarketBeat
ResMed Inc. stock rises Wednesday, still underperforms market - MarketWatch
ResMed Inc (RMD) CFO Brett Sandercock Sells 1,000 Shares - GuruFocus.com
ResMed CFO Sandercock sells $244,230 in stock By Investing.com - Investing.com South Africa
ResMed CFO Sandercock sells $244,230 in stock - Investing.com
ResMed's SWOT analysis: sleep tech giant faces GLP-1 drug challenge - Investing.com
Stifel Financial Corp Has $14 Million Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
National Bank of Canada FI Acquires 19,120 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
'Huge opportunity' ahead for this ASX 200 healthcare stock - MSN
13,712 Shares in ResMed Inc. (NYSE:RMD) Bought by Executive Wealth Management LLC - MarketBeat
iA Global Asset Management Inc. Has $1.40 Million Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
What is Zacks Research's Forecast for ResMed Q2 Earnings? - MarketBeat
William Blair Brokers Boost Earnings Estimates for ResMed - MarketBeat
Returns on Capital Paint A Bright Future For ResMed (NYSE:RMD) - Yahoo Finance
Insiders At ResMed Sold US$17m In Stock, Alluding To Potential Weakness - Simply Wall St
Quantinno Capital Management LP Has $6.02 Million Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
1.18%
자본화:
|
볼륨(24시간):